Novel glimepiride derivatives with potential as double-edged swords against type II diabetes

Archives of Physiology and Biochemistry

Volumn 116, Issue 1, 2010, Pages 3-20

  Muller, Günter ^a   Schulz, Andrea ^a   Hartz, Detlev ^a   Dearey, Elisabeth Ann ^a   Wetekam, Eva Maria ^a   Ökonomopulos, Raymond ^a   Crecelius, Anna ^a   Wied, Susanne ^a   Frick, Wendelin ^a  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

Author keywords

Glycosylphosphatidylinositol anchored proteins; Insulin release; Lipid metabolism; Sulphonylurea

Indexed keywords

ANTIDIABETIC AGENT; GLIMEPIRIDE; INSULIN; SULFONYLUREA DERIVATIVE;

ADIPOCYTE; ANIMAL; ARTICLE; CELL STRAIN COS1; CERCOPITHECUS; DRUG EFFECT; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; PANCREAS ISLET BETA CELL;

ADIPOCYTES; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; DIABETES MELLITUS, TYPE 2; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; SULFONYLUREA COMPOUNDS;

EID: 77949417348     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.3109/13813450903575720     Document Type: Article

References (57)

1. Aguilar-Bryan L, Nichols CG, Wechsler SW, Clement JP 4th, Boyd AE 3rd, Gonzales G, Herrera-Sosa H, Nguy K, Bryan J, Nelson DA. (1995). Cloning of the beta cell high-affinity sulphonylurea receptor: a regulator of insulin secretion. Science 268:423-426
2. Aoki N, Jin-no S, Nakagawa Y, Asai N, Arakawa E, Tamura N, Tamura T, Matsuda T. (2007). Identification and characterization of microvesicles secreted by 3T3-L1 adipocytes: redox-and hormone-dependent induction of milk fat globule-epidermal growth factor 8-associated microvesicles. Endocrinology 148:3850-3862
3. Ashcroft FM, Gribble FM. (1999). ATP-sensitive K+ channels and insulin secretion. Diabetologia 42:903-919
4. Ashfield R, Gribble FM, Ashcroft SJH, Ashcroft FM. (1999). Identification of the high affinity tolbutamide site on the SUR1 subunit of the KATP channel. Diabetes 48:1341-1347
5. Badian M, Korn A, Lehr K-H. (1994). Absolute bioavailability of glimepiride (Amaryl registered) after oral administration. Drug Metab Drug Interact 11:331-339
6. Bähr M, von Holtey M, Müller G, Eckel J. (1995). Direct Stimulation of myocardial glucose transport and glucose transporter-1 (GLUT1) and GLUT4 protein expression by the sulphonylurea glimepiride. Endocrinology 136:2547-2553
7. Cooper DR, Vila MC, Watson JE, Nair G, Pollet RJ, Standaert M, Farese RV. (1990). Sulphonylurea-stimulated glucose transport association with diacylglycerol-like activation of protein kinase C in BC3H-1 myocytes. Diabetes 39:1399-1407.
8. Draznin B, Kao M, Sussman KE. (1987). Insulin and glyburide increase cytosolic free-Ca2+ concentration in isolated rat adipocytes. Diabetes 36:174-177
9. Draznin B, Sussman KE, Eckel RH, Kao M, Yost T, Sherman NA. (1988). Possible role of cytosolic free calcium concentrations in mediating insulin resistance of obesity and hyperinsulinemia. J Clin Invest 82:1848-1852
10. Ducharme NA, Bickel PE. (2008). Lipid droplets in lipogenesis and lipolysis. Endocrinology 149:942-949
11. Fevrier B, Raposo G. (2004). Exosomes: endosomal-derived vesicles shipping extracellular messages. Curr Opin Cell Biol 16:415-421
12. Freyssinet J-M. (2003). Cellular microparticles: what are they bad or good for? J Thromb Haemost 1:1655-1662
13. Fujimoto T, Ohsaki Y, Cheng J, Suzuki M, Shinohara Y. (2008). Lipid droplets: a classic organelle with new outfits. Histochem Cell Biol 130:263-279
14. Gazdar AF, Chick WL, Oie HK, Sims HL, King DL, Weir GC, Lauris V. (1980) Continuous, clonal, insulin-and somatostatin-secreting cell lines established from a transplantable rat islet cell tumor. Proc Natl Acad Sci USA 77:3519-3523
15. Geisen K. (1988). Special pharmacology of the new sulphonylurea glimepiride. Drug Res 38:1120-1130
16. Geisen K, Hitzel V, Oekomonopulos R, Pünter J, Weyer R, Summ HD. (1985). Inhibition of 3H-glibenclamide binding to sulphonylurea receptors by oral antidiabetics. Arzneimittelforschung 35:707-712
17. Gribble FM, Tucker SJ, Seino S, Ashcroft FM. (1998). Tissue specificity of sulphonylureas: studies on cloned cardiac and β-cell KATP channels. Diabetes 47:1412-1418
18. Harris MI. (2000). Health care and health status and outcomes for patients with type 2 diabetes. Diabetes Care 23:754-758
19. Henquin J-C, Garrino M-G, Nenquin M. (1987). Stimulation of insulin release by benzoic acid derivatives related to the non-sulphonylurea moiety of glibenclamide: Structural requirements and cellular mechanisms. Eur J Pharmacol 142:243-251
20. Ikezawa H. (2002). Glyosylphosphatidylinositol (GPI)-anchored proteins. Biol Pharm Bull 25:409-417
21. Inagaki N, Gonoi T, Clement JP 4th, Namba N, Inazawa J, Gonzalez G, Aguilar-Bryan L, Seino S, Bryan J. (1995). Reconstitution of IKATP: an inward rectifier subunit plus the sulphonylurea receptor. Science 270:1166-1170
22. Jahangir A, Terzic A. (2005). K(ATP) channel therapeutics at the bedside. J Mol Cell Cardiol 39:99-112.
23. Jacobs DB, Jung CY. (1985). Sulphonylurea potentiates insulininduced recruitment of glucose transport carrier in rat adipocytes. J Biol Chem 260:2593-2596
24. Kim JH, Kiefer LL, Woychik RP, Wilkison WO, Truesdale A, Ittoop O, Willard D, Nichols J, Zemel MB. (1997). Agouti regulation of intracellular calcium. Role of melanocortin receptor. Am J Physiol 272:E379-84.
25. Kramer W, Geisen K, Müller G. (1996). Characterization of the molecular mode of action of the sulphonylurea, glimepiride, at pancreatic β-cells. Horm Metab Res 28:464-468
26. Kramer W, Müller G, Girbig F, Gutjahr U, Kowalewski S, Hartz D, Summ H-D. (1994) Differential interaction of glimepiride and glibenclamide with the β-cell sulphonylurea receptor: II. Photoaffinity labeling of a 65-kDa protein with [3H]glimepiride. Biochim Biophys Acta 1191:278-290
27. Kramer W, Oekonomopulos R, Pünter J, Summ HD. (1988). Direct photoaffinity labeling of the putative sulphonylurea receptor in rat beta-cell tumor membranes by [3H]glibenclamide. FEBS Lett 229:355-359
28. Maloff BL, Lockwood DH. (1981). In vitro effects of a sulphonylurea on insulin action in adipocytes. J Clin Invest 68:85-90.
29. Martz A, Jo I, Jung CY. (1988). Sulphonylurea binding to adipocyte membrane and potentiation of insulin stimulated hexose transport. J Biol Chem 264:13672-13678
30. Meyer M, Chudziak F, Schwanstecher C, Schwanstecher M, Panten U. (1999). Structural requirements of sulphonylureas and analogues for interaction with sulphonylurea receptor subtypes. Br J Pharmacol 128:27-34.
31. Mikhailov MV, Mikhailova EA, Ashcroft SJH. (2001). Molecular structure of the glibenclamide binding site of the β-cell KATP channel. FEBS Lett 499:154-160
32. Müller G. (2005). The mode of action of glimepiride-beyond insulin secretion. Curr Med Chem 5:499-518.
33. Müller G. (2000). The molecular mechanism of the insulin-mimetic/ sensitizing activity of the antidiabetic sulphonylurea drug amaryl. Mol Med 6:907-933
34. Müller G, Geisen K. (1996). Characterization of the molecular mode of action of the sulphonylurea, glimepiride, at adipocytes. Horm Metab Res 28:469-487
35. Müller G, Hanekop N, Wied S, Frick W. (2002). Cholesterol depletion blocks redistribution of lipid raft components and insulin-mimetic signaling by glimepiride and phosphoinositolglycans in rat adipocytes. Mol Med 8:120-136
36. Müller G, Hartz D, Pünter J, Ökonomopulos R, Kramer W. (1994a). Differential interaction of glimepiride and glibenclamide with the β-cell sulphonylurea receptor I. Binding characteristics. Biochim Biophys Acta 1191:267-277
37. Müller G, Jordan H, Jung C, Kleine H, Petry S. (2003). Analysis of lipolysis in adipocytes using a fluorescent fatty acid derivative. Biochimie 85:1245-1256
38. Müller G, Jung C, Straub J, Wied S. (2009a). Induced release of membrane vesicles and exosomes from rat adipocytes containing lipid droplet, lipid raft and glycosylphosphatidylinositol-anchored proteins. Cellular Signalling 21:324-338
39. Müller G, Jung C, Wied S, Biemer-Daub G. (2009b). Induced translocation of glycosylphosphatidylinositol-anchored proteins from lipid droplets to adiposomes in rat adipocytes. Br J Pharmacol 158:749-770.
40. Müller G, Jung C, Wied S, Welte S, Jordan H, Frick W. (2001). Redistribution of glycolipid raft domain components induces insulin-mimetic signaling in rat adipocytes. Mol Cell Biol 21:4553-4567
41. Müller G, Korndörfer A, Saar K, Karbe-Thönges B, Fasold H, Müllner S. (1994b). 4'-amino-benzamido-taurocholic acid selectively solubilizes glycosyl-phosphatidylinositol-anchored membrane proteins and improves lipolytic cleavage of their membrane anchors by specific phospholipases. Arch Biochem Biophys 309:329-340
42. 2 and the sulphonylurea drug, glimepiride, in rat adipocytes. Biochemistry 47:1274-1287
43. Müller G, Schulz A, Wied S, Frick W. (2005). Regulation of lipid raft proteins by glimepiride-and insulin-induced glycosylphosphatidylinositol- specific phospholipase C in rat adipocytes. Biochem Pharmacol 69:761-780
44. Müller G, Wied S. (1993). The sulphonylurea drug glimepiride stimulates glucose transport, glucose transporter translocation, and dephosphorylation in insulin-resistant rat adipocytes in vitro. Diabetes 39:1399-1407
45. Müller G, Wied S, Jung C, Over S. (2008b). Translocation of glycosylphosphatidylinositol-anchored proteins to lipid droplets and inhibition of lipolysis in rat adipocytes is mediated by reactive oxygen species. Br J Pharmacol 154:901-913
46. 2 and the antidiabetic sulphonylurea drug, glimepiride, in rat adipocytes. Eur J Pharmacol 597:6-18.
47. 2 and the sulphonylurea drug, glimepiride, in rat adipocytes depends on cAMP degradation by lipid droplets. Biochemistry 47:1259-1273
48. 2 and the sulphonylurea drug, glimepiride. Mol Pharmacol 73:1513-1529
49. Nichols CG. (2006). KATP channels as molecular sensors of cellular metabolism. Nature 440:470-476
50. Nosjean O, Briolay A, Roux B. (1997). Mammalian GPI proteins: sorting, membrane residence and functions. Biochim Biophys Acta 1331:153-186
51. Rajan A, Luo Z-T, Kahn BB, Comstock JP, Cushman SW, Boyd III AE. (1994). Do adipocytes contain high affinity sulphonylurea receptors? Endocrinology 134:1581-1588
52. Sakura H, Ammälä C, Smith PA, Gribble FM, Ashcroft FM. (1995) Cloning and functional expression of the cDNA encoding a novel ATP-sensitive potassium channel subunit expressed in pancreatic beta-cells, brain heart and skeletal muscle. FEBS Lett 377:338-344
53. Schwanstecher C, Meyer M, Schwanstecher M, Panten U. (1998). Interaction of N-benzoyl-D-phenylalanine and related compounds with the sulphonylurea receptor of β-cells. Br J Pharmacol 123:1023-1030
54. Schwanstecher M, Männer K, Panten U. (1994). Inhibition of K+ channels and stimulation of insulin secretion by the sulphonylurea glimepiride in relation to its membrane binding in pancreatic islets. Pharmacology 49:105-111
55. Shi H, Moustaid-Moussa N, Wilkison WO, Zemel MB. (1999). Role of the sulphonylurea receptor in regulating human adipocyte metabolism. FASEB J 13:1833-1838
56. Song D-K, Ashcroft FM. (2001). Glimepiride block of cloned β-cell, cardiac and smooth muscle KATP channels. Br J Pharmacol 133:193-199
57. Wang PH, Moller D, Flier JS, Nayak RC, Smith RJ. (1989). Coordinate regulation of glucose transporter function, number, and gene expression by insulin, sulphonylureas in L6 rat skeletal muscle cells. J Clin Invest 84: 62-67